Kansas Lawmakers Advance Bill to Ban Kratom, Raising Alarms for Industry and Consumers

Kansas Lawmakers Advance Bill to Ban Kratom, Raising Alarms for Industry and Consumers

TOPEKA, KS – March 28, 2026 – Kansas lawmakers have made a critical move to ban kratom statewide, with the House passing a bill that would classify it as a Schedule I controlled substance and forwarding it to the Governor. This eleventh-hour legislative push, revived in a new bill as the 2026 session concludes, proposes to place kratom in the same category as heroin, LSD, and marijuana, effectively outlawing its possession, sale, and manufacturing across the state.

What Happened

The legislative action primarily centers around Kansas Senate Bill 497 (SB 497), or a new bill incorporating its provisions, which aims to list both kratom and its potent derivative, 7-hydroxymitragynine (7-OH), as Schedule I drugs. Proponents of the ban, including the Kansas Attorney General's Office and the Kansas Bureau of Investigation (KBI), argue that such a classification is necessary due to public health concerns, the potential for addiction, and the highly potent nature of concentrated 7-OH. They suggest a blanket ban would streamline enforcement and eliminate loopholes that could allow stronger products to circulate. David Kuntz of Clinical Reference Laboratory in Lenexa noted a significant increase in 7-OH detection, in some instances surpassing common opioids.

This legislative effort contrasts sharply with a recent approach taken by Kansas City, Missouri, which opted to ban only synthetic kratom products (7-OH) while regulating natural kratom leaf and extracts, including age restrictions and licensing requirements. Previous attempts in Kansas, such as House Bill 2230 in the 2025-2026 session, sought to enact a Kratom Consumer Protection Act (KCPA) to regulate kratom as a food product with age limits and prohibitions on adulterated sales, but this bill did not advance.

Why It Matters to Kratom Merchants and Consumers

For kratom merchants, the passage of this bill would be "catastrophic," leading to an immediate cessation of legal sales and potentially exposing businesses and individuals to criminal charges. This shift from an unregulated, albeit often scrutinized, market to a Schedule I classification creates immense legal and operational risks. Consumers who rely on kratom for pain relief or as an alternative to opioids would lose access to these products, potentially pushing them towards riskier, unregulated markets. Opponents of the ban, including some lawmakers, argue that a blanket prohibition is overly broad and lacks sufficient scientific backing, advocating instead for sensible regulation.

Compliance Implications

The direct compliance implication of a statewide ban is clear: kratom products would become illegal. For payment compliance analysts, this means any merchant processing kratom transactions in Kansas would immediately be in violation of the law. Payment processing accounts for such "high-risk" industries are already under intense scrutiny and would face immediate termination. Merchants operating across state lines must be acutely aware of this patchwork of laws, as legality in one state does not guarantee legality in another. This legislative development underscores the volatile regulatory landscape surrounding kratom and the critical need for merchants to stay informed and agile.

What High-Risk Merchants Need to Know About COAs, Lab Testing, and Regulatory Compliance

Even in the face of outright bans or uncertain regulatory environments, maintaining stringent quality control and transparency remains paramount for high-risk kratom merchants.

• Certificates of Analysis (COAs): These documents, issued by independent, accredited third-party laboratories, are vital. They provide detailed information about a product's composition, confirming the presence and levels of key alkaloids like mitragynine and 7-OH. Crucially, COAs also verify the absence of harmful contaminants such as heavy metals (e.g., arsenic, lead, cadmium, mercury), pesticides, and microbial pathogens (e.g., mold, salmonella, coliforms). Reputable vendors should readily provide batch-specific COAs, demonstrating their commitment to product safety, purity, and potency.
• Lab Testing: Regular, independent third-party lab testing is the cornerstone of consumer safety and merchant credibility. These tests ensure products are unadulterated and meet established safety and purity standards, even in the absence of federal regulation.
• Regulatory Compliance: Merchants must constantly monitor federal, state, and local legislative developments. In states where kratom is regulated, compliance typically involves age restrictions (often 21+), clear and accurate labeling of ingredients and alkaloid content, disclaimers, and adherence to quality testing protocols. Some states also mandate licensing for kratom vendors. Proactive engagement with legal counsel and industry associations is essential to navigate this complex and rapidly evolving landscape. While a ban in Kansas would negate immediate compliance efforts for sales within the state, maintaining high standards globally can help build industry credibility and potentially influence future policy decisions in other jurisdictions.